|
Your Source for the Latest Patent Information |
User Functions
Categories
Archives
Search
Syndication
What is RSS?
RSS 0.92:
RSS 1.0:
RSS 2.0:
Atom:
Credits
|
|
|
GEN-ERIC Patent News
Your Source for the Latest Patent Information
04/19/05
6,881,123 Natural shape enhancing brassiere
Issued: April 19, 2005
Filed: October 15, 2003
U.S. Class: 450/39
Abstract: A natural shape enhancing brassiere comprising a pair of idealized-shaped breast cups centrally joined and supported on a woman's upper chest by use of a surrounding band and, optionally, shoulder straps. Each idealized-shaped breast cup is in the form of a multi-layer construction comprising an intermediate foam layer configured with an idealized upper breast slant and an idealized lower breast convex curve, an outer shell layer composed from a material capable of conforming to the intermediate foam layer and an inner lining layer.

Posted by GEN-ERIC at 10:45:22 am into the following categories: Patents of the Day
04/19/05
6,860,466 Sub-lethal, wireless projectile and accessories
Issued: April 19, 2005
Filed: June 20, 2003
U.S. Class: 102/275.7
Abstract: The invention is a circuit capable of being positioned in a variety of wireless projectile and of delivering a series of pulsed electric discharges in two wave frequencies so as to stun and disable a target individual. The projectiles are adapted to be discharged from a different types of devices and powered by explosive, pneumatic, or manual means. At least one mode includes the ability to deliver a stunning physical blow in addition to the electric shock. The device is sub-lethal, but totally disabling in effects on a target individual.

Posted by GEN-ERIC at 10:44:51 am into the following categories: Patents of the Day
04/19/05
6,882,285 PDA watch
Issued: April 19, 2005
Filed: December 15, 2000
U.S. Class: 340/815.53
Abstract: A personal data assistant ("PDA") watch uses a "character wheel," or a "data dial," to enter information, or characters, into the PDA watch. Such a dial makes the entering of data much quicker by taking advantage of the flexibility of the human wrist. A dial containing the character set disbursed around its circumference can be turned to indicate which character the user wishes to enter. The selection of a particular symbol/character can then be made by depressing the dial or some other input button.

Posted by GEN-ERIC at 10:44:32 am into the following categories: Patents of the Day
04/19/05
Posted by GEN-ERIC at 10:14:58 am into the following categories: OG Notice Links
04/19/05
Posted by GEN-ERIC at 10:14:23 am into the following categories: OG Notice Links
04/19/05
Microsoft might have to delay shipment of an upgrade to Windows Server 2003 and the company's next major operating system, Longhorn, as a result of an injunction made by a U.S. District Court in response to claims by Alacritech, a start-up company, that Microsoft appropriated its technology without a license. The preliminary ruling prevents Microsoft from using its TCP offload architecture -- code-named Chimney -- that it has included in its Windows Server 2003 and Longhorn. According to Alacritech, it met with Microsoft in 1998 and described its architecture in detail under a nondisclosure agreement. In April 1999, it delivered to Microsoft a detailed architecture document for integrating SLIC technology into the Windows operating system. In June, Alacritech said, Microsoft cut off communication with the firm. "After Alacritech discovered that Microsoft Chimney is based on intellectual property that we developed, patented and own, we offered Microsoft a license," said Larry Boucher, president and CEO, Alacritech. "Microsoft rejected licensing terms that would be acceptable to us." The company then sued Microsoft in Federal District Court in August 11, 2004, alleging that Chimney is based on technology that it began patenting in 1997. Microsoft has claimed that it developed Chimney independently.
Posted by GEN-ERIC at 12:08:01 am into the following categories: In The News
04/19/05
Competitive Technologies, Inc. announced today the receipt of $1.15 million from their homocysteine assay patent infringement case against Laboratory Corporation of America Holdings (LabCorp). CTT's share of the payment is approximately $230,000. The funds represent a payment against attorney's fees, court costs and post-judgment interest awarded to CTT and its clients. In June 2004 the US Court of Appeals for the Federal Circuit affirmed the CDC's November 2002 decision upholding the validity of the patent. CTT has successfully signed license agreements and is collecting royalties from companies performing the majority of homocysteine assays in the marketplace. These companies include Bayer, Abbott, Roche, Quest, Diagnostic Products and GENCHEM. CTT has an active program of collecting previously withheld royalties from all organizations involved in the homocysteine assay process. The assay patent is derived from discoveries made by CTT's clients, Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University.
Posted by GEN-ERIC at 12:05:57 am into the following categories: In The News
04/19/05
Dr Reddy’s Laboratories (DRL) has lost a key patents case against drug major Eli Lilly & Company. A US district court upheld the patent validity of Zyprexa, Lilly’s blockbuster drug to treat schizophrenia. DRL, along with Ivax Corp and Teva Pharmaceuticals, failed to convince Judge Richard Young that they had strong evidence of the patent’s validity. The decision arose from a May 2001 suit by Eli Lilly against these companies. Had DRL been successful, it would have resulted in the company making a generic version of the drug. DRL had earlier won a patent lawsuit involving Lilly. This case, concerning anti-depressant Prozac, brought the company a windfall of $60 million. DRL has now decided to appeal against today’s decision in a higher court. “We are disappointed by the order and will appeal against it to the Federal Circuit. Despite the adverse ruling, our strategy remains unchanged and we continue to make consistent progress towards building a sustainable generics business in the US,” DRL chief executive G. V. Prasad said.
Posted by GEN-ERIC at 12:04:42 am into the following categories: In The News
|
|
Calendar
Links
|